FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Floxuridine for Injection, USP
Status: Discontinuation
»Therapeutic Categories: Oncology

Fresenius Kabi USA, LLC (New 09/30/2020)

Company Contact Information:
888-386-1300

Presentation Posting Date Related Information
500 mg per vial (NDC 63323-145-07_ 09/30/2020 Discontinued: May 30, 2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English